SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-122466
Filing Date
2023-11-30
Accepted
2023-11-30 16:59:28
Documents
23
Period of Report
2023-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2331641d4_8k.htm   iXBRL 8-K 41310
2 EXHIBIT 1.1 tm2331641d4_ex1-1.htm EX-1.1 277268
3 EXHIBIT 4.1 tm2331641d4_ex4-1.htm EX-4.1 92721
4 EXHIBIT 4.2 tm2331641d4_ex4-2.htm EX-4.2 101244
5 EXHIBIT 5.1 tm2331641d4_ex5-1.htm EX-5.1 15733
6 EXHIBIT 5.2 tm2331641d4_ex5-2.htm EX-5.2 11018
7 EXHIBIT 99.1 tm2331641d4_ex99-1.htm EX-99.1 12676
11 GRAPHIC tm2331641d4_ex5-1img003.jpg GRAPHIC 4116
12 GRAPHIC tm2331641d4_ex5-2img004.jpg GRAPHIC 4325
13 GRAPHIC tm2331641d4_ex5-2img005.jpg GRAPHIC 11454
14 GRAPHIC tm2331641d4_ex5-2img006.jpg GRAPHIC 8133
15 GRAPHIC tm2331641d4_ex99-1img001.jpg GRAPHIC 19257
  Complete submission text file 0001104659-23-122466.txt   931232

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA seel-20231127.xsd EX-101.SCH 3015
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE seel-20231127_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE seel-20231127_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2331641d4_8k_htm.xml XML 3308
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 231456484
SIC: 2834 Pharmaceutical Preparations